fbpx
en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu
ASTRO Endorses Stereotactic Body Radiation Therapy As First-Line Prostate Cancer Treatment Option

 

The American Society for Radiation Oncology has announced the classification of stereotactic body radiation therapy as a first-line treatment option for prostate cancer. As a first-line treatment, SBRT can be considered a primary form of treatment for prostate cancer. The results of long-term clinical trials supporting the safety and efficacy of stereotactic body radiation in […]

 

Learn More

 

 

Spotlight On: Prostate Cancer Foundation

 

The Prostate Cancer Foundation (PCF) is a dynamic organization committed to funding cutting-edge prostate cancer research. Since 1993, the PCF has funded more than 1,600 programs at nearly 200 research facilities around the world. In 2012, the organization raised a record $47 million and expanded their research programs to China. Each year, the PCF partners […]

 

Learn More

 

 

Oklahoma CyberKnife Treats Increased Number of Prostate Cancer Patients

 

A greater number of men in Oklahoma are now able to receive cancer care from Oklahoma CyberKnife due to expanded Medicare coverage for prostate cancer patients. Oklahoma CyberKnife began offering CyberKnife® treatment to prostate cancer patients with commercial insurance when it opened in 2008 as a service of Hillcrest Medical Center. Last year, the center […]

 

Learn More

 

 

Prostate Cancer by the Numbers: American Cancer Society Facts and Figures

 

Have you seen the latest prostate cancer facts and figures released by the American Cancer Society? We’ve included some noteworthy stats below. To learn more, visit the prostate cancer section of the American Cancer Society website. This post is part of a series dedicated to addressing one of the most important health issues facing men […]

 

Learn More

 

 

Oklahoma CyberKnife to Offer Cancer Treatment Education at local Movember Event

 

In honor of the global “Movember” movement, Oklahoma CyberKnife will join local businesses Elephant In The Room Lounge and the Style Lab on Thursday, Dec. 6 for an event to celebrate Tulsa-area men who have grown beards and mustaches to raise awareness for cancers affecting men on Thursday, Dec. 6. Attendees can enjoy shaves offered […]

 

Learn More

 

 

Prostate Cancer Treatment Advancements Improve Survivorship

 

One in six men will face a prostate cancer diagnosis in his lifetime, totaling to 240,000 new cases this year as estimated by the American Cancer Society. Fortunately, advancements in cancer treatment have allowed nearly eight times as many men to count themselves as survivors of the pervasive disease.

September is National Prostate Cancer Awareness Month, and Oklahoma CyberKnife encourages men seeking prostate cancer treatment to educate themselves on the range of options available to treat the disease.

“Advancements made in prostate cancer treatment have given patients the ability to take control of their diagnosis,” said Dr. Diane Heaton, Oklahoma CyberKnife medical director. “Choosing which treatment approach is most appropriate for your specific case and best suits your lifestyle is pivotal not only for the long term outcome of treatment, but also your quality of life.”

 

Learn More

 

 

Oklahoma CyberKnife Shares Men’s Health Awareness Tips

 

June is dedicated to raising awareness and prevention of the preventable health problems men face while encouraging men to seek regular medical advice and early treatment for disease or injury. One of the common health threats to men is prostate cancer. In 2012, the American Cancer Society estimates about 241,740 new diagnoses of prostate cancer. […]

 

Learn More

 

 

TrailBlazer Now Covering CyberKnife Treatment for Prostate Cancer

 

TrailBlazer Health Enterprises, one of fifteen independent regional contractors for Medicare, has announced that it will begin covering CyberKnife treatment of prostate cancer as of today, Jan. 30, 2012, provided that patients are enrolled in a clinical study. This policy revision expands Oklahomans’ access to a treatment that was approved by the Food & Drug Administration more than a decade ago and has been covered by the other 46 states that are not part of the TrailBlazer region, which includes Oklahoma, Texas, Colorado and New Mexico.

 

Learn More

 

 

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

 

According to research presented at the recent 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), high dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity, and excellent cancer control rates.    Although prostate tumors generally respond well to radiation […]

 

Learn More

 

 

Prostate Cancer Treated More Aggressively in the City

 

According to a recent study published in the journal Prostate Cancer and Prostatic Diseases, urban men with localized prostate cancer may be more likely to get surgery or radiation than their rural peers.  Men had 23 percent higher odds of getting these aggressive treatments when they lived in densely populated U.S. counties than if they […]

 

Learn More